Table 1. Baseline Demographics and Markers of Immune Activation and Arterial Inflammation (mITT population).
Normally distributed data are reported as mean ± standard deviation and non-normally distributed data are reported as median (interquartile range), except for cardiac biomarkers which are all presented as median (interquartile range). Data are shown for mITT population.
| Pitavastatin | Pravastatin | |
|---|---|---|
| Age | 50 (46,56) N = 113 |
50 (45,56) N = 117 |
| Sex, % Male | 85% (96/113) | 89% (104/117) |
| Race White Black Asian Other |
84% (95/113) 13% (15/113) 1% (1/113) 2% (2/113) |
77% (90/117) 18% (21/117) 1% (1/117) 4% (5/117) |
| Hispanic | 25% (28/113) | 27% (32/117) |
| Hepatitis B/C | 8% (9/113) | 10% (12/117) |
| eGFR (ml/min/1.73m2) | 78 (70, 90) N = 113 |
78 (71, 90) N = 117 |
| TSH (mIU/L) | 1.6 (1.2, 2.3) N = 113 |
1.5 (1.1, 2.2) N = 117 |
| Total Cholesterol (mg/dL) | 236 (217, 260) N = 113 |
235 (214, 256) N = 117 |
| HDL-C (mg/dL) | 47 (39, 55) N = 113 |
47 (41, 56) N = 117 |
| LDL-C (mg/dL) | 155 (133, 172) N = 108 |
152 (136, 170) N = 116 |
| Triglycerides (mg/dL) | 149 (112, 220) N = 113 |
155 (113, 211) N = 117 |
| BMI (kg/m2) | 26 (24, 30) N = 113 |
28 (25, 31) N = 117 |
| Framingham Risk Score (%) | 5 (3, 10) N = 113 |
6 (3, 8) N = 117 |
| Log HIV-1 Viral Load (copies/ml) | 1.1±0.2 N = 112 |
1.1±0.2 N = 115 |
| CD4 count (cells/mm3)* | 650 (441, 859) N = 112 |
561 (433, 751) N = 117 |
| sCD163 (ng/mL) | 1,030 (731, 1,369) N = 112 |
949 (737, 1,139) N = 117 |
| hsIL-6 (pg/mL) | 0.9 (0.8, 1.4) N = 112 |
1.1 (0.7, 1.7) N = 117 |
| MCP-1 (pg/ml) | 142.2 (110.9,189.2) N = 112 |
142.6 (107.4, 180.7) N = 115 |
| sCD14 (ng/mL) | 1,801 (1,348, 2,276) N = 112 |
1,752 (1,382, 2,057) N = 117 |
| oxLDL (U/L) | 76.8 (60.6, 93.3) N = 112 |
77.9 (63.9, 88.6) N = 116 |
| Lp-PLA-2 (ng/mL) | 194 (157, 227) N = 112 |
183 (137, 240) N = 117 |
No differences between baseline values unless indicated,
P-value =0.03
Abbreviations: eGFR, estimated glomerular filtration rate; TSH, thyroid stimulating hormone; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; BMI, body mass index; HIV-1, Human Immunodeficiency Virus-1; sCD163, soluble CD163; hsIL-6, high sensitivity interleukin-6, MCP-1, monocyte chemoattractant protein-1; sCD14, soluble CD14; oxLDL, oxidized low density lipoprotein, Lp-PLA2, lipoprotein-associated phospholipase A2